Trial · NCT05871151
Outcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN | |
| PRIMARY | Six Minute Walk Test (6MWT) | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | One participant in the sham group and one in the active group did not complete the 6MWT at follow-up. One participant in the sham group did not complete the 6MWT at post-test. | feet | MEAN |
| PRIMARY | Ten Meter Walk Test (10MWT) | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Self-selected gait speed | seconds | MEAN |
| PRIMARY | Mini-Best Test | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN | |
| PRIMARY | Functional Gait Assessment (FGA) | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN | |
| PRIMARY | mCTSIB | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN | |
| SECONDARY | MoCA | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN | |
| SECONDARY | DKEFS Color Word Interference Test - Condition One | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | One participant in the sham group did not complete the CWI. | Scores on a scale | MEAN |
| SECONDARY | DKEFS Color Word Interference Test - Condition Two | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN | |
| SECONDARY | DKEFS Color Word Interference - Condition Three | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | One of the participants in the sham group did not complete CWI-3 at follow-up. | Scores on a scale | MEAN |
| SECONDARY | DKEFS Verbal Fluency Test | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN | |
| SECONDARY | Digit Span Test | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN | |
| SECONDARY | Digit Symbol Substitution Test | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | One participant in the sham group and one in the active group did not complete the DSST at post-test. | Scores on a scale | MEAN |
| SECONDARY | Flanker | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN | |
| SECONDARY | Promise Neuro-QOL (Ability) | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | t-score | MEAN | |
| SECONDARY | SF-36 | Baseline, immediately post-treatment (after 12 study visits, around 4-6 weeks), and at follow-up (4 weeks after last treatment) | Scores on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05871151/outcomes